173 related articles for article (PubMed ID: 30643458)
21. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
[TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
[TBL] [Abstract][Full Text] [Related]
23. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
Xie R; Li B; Jia L; Li Y
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
[TBL] [Abstract][Full Text] [Related]
24. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis.
Zhao J; Kuang D; Cheng X; Geng J; Huang Y; Zhao H; Yang Z
Open Life Sci; 2023; 18(1):20220687. PubMed ID: 37954103
[TBL] [Abstract][Full Text] [Related]
26. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
Li J; Wang Y; Wang X; Yang Q
World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
[TBL] [Abstract][Full Text] [Related]
27.
Yan P; He Y; Xie K; Kong S; Zhao W
PeerJ; 2018; 6():e6092. PubMed ID: 30568862
[TBL] [Abstract][Full Text] [Related]
28. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
[TBL] [Abstract][Full Text] [Related]
29. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
30. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
31. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
32. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
34. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
Dong S; Liang J; Zhai W; Yu Z
Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
[TBL] [Abstract][Full Text] [Related]
35. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Qu G; Wang H; Yan H; Liu G; Wu M
Front Oncol; 2022; 12():857619. PubMed ID: 35296026
[TBL] [Abstract][Full Text] [Related]
36. High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.
Luo X; Xu S; Zhong Y; Tu T; Xu Y; Li X; Wang B; Yang F
Oncol Lett; 2019 Dec; 18(6):6171-6179. PubMed ID: 31788092
[TBL] [Abstract][Full Text] [Related]
37. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
38. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
39. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis.
Xu Y; Geng R; Yuan F; Sun Q; Liu B; Chen Q
PeerJ; 2019; 7():e6560. PubMed ID: 30867991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
